Ferre L, Mogavero A, Clarelli F, Moiola L, et al. Early evidence of disease activity during fingolimod predicts medium-term
inefficacy in relapsing-remitting multiple sclerosis. Mult Scler 2020 Sep 25:1352458520961690. doi: 10.1177/1352458520961690.
PMID: 32975468